Metabolic & Weight Loss

AOD-9604, CJC-1295 and ipamorelin form a three-ingredient research combination often discussed for fat loss and body composition. The components have…

Cagrilintide plus semaglutide is being studied as CagriSema, a combination that targets amylin and GLP-1 pathways. Unlike many peptide combinations…

Eloralintide is an investigational amylin receptor agonist being developed for obesity. It is not a GLP-1 medicine. Human trials have…

Survodutide is an investigational peptide that activates GLP-1 and glucagon receptors. Researchers are studying it for obesity and metabolic liver…

Pancragen is a four-amino-acid peptide studied for pancreatic function and age-related changes in glucose metabolism. Its research includes cell experiments,…

SLU-PP-332 is an experimental small molecule studied for effects on energy metabolism and exercise endurance in mice. It activates estrogen-related…

Adipotide is an experimental compound designed to target blood vessels supporting white fat tissue. It produced weight loss in animal…

5-Amino-1MQ is an experimental small-molecule inhibitor of nicotinamide N-methyltransferase, usually shortened to NNMT. It is not a peptide, despite often…

Tirzepatide is a prescription peptide medicine that acts on two hormone receptors, GIP and GLP-1. It can lower blood sugar…

Retatrutide is an investigational weight-loss medicine that activates three hormone receptors: GIP, GLP-1 and glucagon. Large Phase 3 trials now…